Routine Data | MICS | Paper records | eRegistry | ||
---|---|---|---|---|---|
Morbidity & mortality | Maternal lives saved | 16 | 5 | 35 | 39 |
Newborn lives saved | 0 | 0 | 49 | 39 | |
Stillbirths averted | 239 | 45 | 285 | 270 | |
Maternal anemia cases averted | 0 | 0 | 16,444 | 42,064 | |
Interventions averting mortality and morbidity | Maternal | Pre-eclampsia management (100%) | Hypertensive disease management (75%); Pre-eclampsia management (25%) | Hypertensive disease management (41%); Pre-eclampsia management (59%) | Hypertensive disease management (45%); Pre-eclampsia management (55%) |
Newborn | – | – | Tetanus toxoid (100%) | Tetanus toxoid (100%) | |
Stillbirth | Pre-eclampsia management (84%); diabetes management (16%) | Pre-eclampsia management (52%); diabetes management (48%) | Pre-eclampsia management (83%); diabetes management (17%) | Pre-eclampsia management (82%); diabetes management (18%) | |
Anemia | – | – | Iron Folate (100%) | Iron Folate (100%) | |
Rates, ratios, percentages | Maternal Mortality Ratio (2017/2025) % change | 46/44 3% | 46/45 1% | 46/43 6% | 46/43 6% |
Neonatal Mortality Rate (2017/2025) % change | 11/11 0% | 11/11 0% | 11/11 < 1% | 11/11 < 1% | |
Stillbirth Rate (2017/2025) % change | 7/7 2% | 7/7 < 1% | 7/7 3% | 7/7 3% | |
Pregnant women with anemia (%) (2017/2025) % change | 27/27 0% | 27/27 0% | 37/36 3% | 38/35 8% |